Latest News

You can find our latest news below

01 Nov, 2024

Join us for an insightful webinar on cardiac troponins, featuring Dr. Allan Jaffe as the keynote speaker and Dr. Ivan Katrukha as the featured speaker.

25 Oct, 2024

Strong bones are the foundation of overall good health, yet bone health issues often go undetected until an unexpected disease starts to show its prevalence.

22 Oct, 2024

All Hytest SARS-CoV-2 nucleoprotein (NP) antibodies (Cat. #3CV4), including monoclonal antibodies (MAbs) C706, C524, C518, C715, and C527, target the N-terminal part of the nucleoprotein, specifically the region N47-A173. 

04 Oct, 2024

We will be attending Medica 2024 in mid-November.

27 Sep, 2024

Cardiac troponins I (cTnI) and T (cTnT) are established biomarkers of acute myocardial infarction (AMI). Together with troponin С (TnC), they form a ternary troponin complex (ITC-complex) that represents a significant portion of troponins released into the bloodstream following cardiomyocyte necrosis

09 Aug, 2024

In this latest article, the authors further discuss the effects of heparin on the measurement of cardiac isoforms of cTnI and cTnT.

27 Jun, 2024

As we celebrate our 30th anniversary, Hytest is proud to offer a special opportunity to our valued customers. Experience the reliability of our tumor markers.This exclusive offer is our way of saying thank you for your continued tr As we celebrate our 30th anniversary, Hytest is proud to offer a special opportunity to our valued customers. Experience the reliability of our tumor markers.This exclusive offer is our way of saying thank you for your continued trust and support. ust and support.

27 Jun, 2024

To help find better solutions in tackling tumor cancers investigations, we are very much delighted to announce that our new product, mouse monoclonal antibody (MAb) 1X5cc is launched today!

26 Jun, 2024

In collaboration with the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the European Federation of Laboratory Medicine (EFLM), Hytest has proudly demonstrated its commitment to advancing scientific research in the field of cardiovascular diseases. By sponsoring awards, Hytest has consistently recognized and honoured outstanding work in cardiovascular diagnostics. 

19 Jun, 2024

We will be attending the 2024 ADLM Clinical Lab Expo from July 28 to August 1.

18 Jun, 2024

By choosing to buy locally, you not only support the North American branch but also ensure a smoother, more cost-effective purchasing experience.

10 Jun, 2024

We are excited to announce the launch of a new recombinant Anti-CA-125 antibody RX16 (Cat# 4C29).

29 May, 2024

May is Cancer Survivor Month. We honor the strength, resilience, and courage of cancer survivors around the world.

15 May, 2024

We are excited to announce the launch of a new recombinant Glial Fibrillary Acidic Protein (GFAP) antigen, Cat# 8G47.

11 Apr, 2024

Hytest is pleased to announce the addition of recombinant monoclonal antibodies RC3A6 and RC8E2 (Cat. # 2I1) to our Insulin product portfolio.

28 Mar, 2024

Our monoclonal antibodies (MAbs) can recognize up to 16 different strains of the influenza A virus. 

01 Mar, 2024

Meet HyTest team at the China Association of Clinical Laboratory Practice Expo!

01 Mar, 2024

Launch of HyTest’s latest monoclonal antibodies targeting the nucleoprotein of influenza B virus!

01 Mar, 2024

The Brain Injury Association of America (BIAA) designates March as a month to raise awareness about brain injuries.

01 Mar, 2024

We are pleased to inform you that Hytest North America, a subsidiary of Hytest Ltd, will launch local operations in March 2024!

Do you need samples?

We are happy to make you an offer